5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Bajaj Healthcare Ltd.

•
bajajhealth.comBSE: 539872NSE: BAJAJHCARE
Market Cap₹ 1,125 Cr.
Current Price
High / Low₹ 516 / 272
Stock P/E48.8
Book Value₹ 162
Price to Book1.83
Dividend Yield0.45 %
ROCE7.0 %
ROE4.3 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2022 • Mfg of Bulk Drugs: 86.9% • Formulation & Sales of Medicines: 13.1%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.45x)
  • Company generates healthy free cash flow
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 54.8% versus prior year
  • Promoter holding has decreased over last 2 years: -9.1pp
  • Company has a low return on equity of 3.9% over last 3 years
  • Company has a low return on capital employed of 6.8%
  • Company's sales have been declining over the last five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.BAJAJHCARE334.1048.851124.750.4513.7012.46165.6311.287.0417.36
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
130101109134132133123154149148161153166
1088289118108109101143124121131130150
Operating Profit22192016252522122527312316
OPM %16.76%18.72%17.99%11.97%18.53%18.42%17.62%7.61%16.47%18.22%19.03%14.82%9.45%
011-3813214122-301
Interest9876886656666
Depreciation6777777867787
Profit before Tax756-3510121212151619-2116
Tax %-1.74%2.29%12.66%8.96%21.22%33.01%-28.41%1.11%16.17%21.99%16.32%6.73%15.59%
Net Profit756-32881512121216-1914
2.551.862.00-11.592.912.964.663.673.853.955.10-6.084.07

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
207290325410657680646473543611628
176250282362521561534397460506532
Operating Profit31394348136119111768310596
OPM %14.88%13.62%13.21%11.78%20.76%17.45%17.26%16.12%15.22%17.17%15.28%
2217712-3619-26-26
Interest88878131830282223
Depreciation1111111216181728282829
Profit before Tax142324361199078-17462931
Tax %42.84%33.05%32.52%30.02%30.05%20.40%18.74%14.09%6.69%26.32%25.34%
Net Profit8151625837164-14432123
EPS0.000.000.000.0030.1125.8715.59-5.1913.596.33—
Dividend Payout %0.00%4.54%0.00%0.00%4.57%5.80%4.34%-19.26%7.36%23.69%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
-1%
3 Years:
-2%

COMPOUNDED PROFIT GROWTH

10 Years:
7%
5 Years:
-28%
3 Years:
-37%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
-4%
1 Year:
-23%

RETURN ON EQUITY

10 Years:
16%
5 Years:
11%
3 Years:
4%
Last Year:
4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 11

₹ 0.30

Rs.1.5000 per share(30%)Final Dividend

2025

Sep 19

₹ 0.20

Rs.1.0000 per share(20%)Final Dividend

2024

Sep 23

₹ 0.20

Rs.1.0000 per share(20%)Final Dividend

2023

Sep 22

₹ 0.20

Rs.1.0000 per share(20%)Final Dividend

2022

Sep 22

₹ 0.30

Rs.1.5000 per share(30%)Final Dividend

2021

Sep 28

₹ 0.05

Rs.0.5000 per share(5%)Special Dividend

2021

Sep 28

₹ 0.05

30/10/2021 Equity Rs.0.5000 per share(5%)Special Dividend

2020

Dec 1

₹ 0.05

Rs.0.5000 per share(5%)Special Dividend

2018

Sep 19

₹ 0.10

Rs.1.0000 per share(10%)Dividend

2026

Sep 4

₹ 0.30

Rs.1.5000 per share(30%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital77714141414141617
92107122164245315354265433515
66767282168243415301199224
Trade Payables19433057691058589100115
35353526304532756741
Total Liabilities219268267343526721899743814913
128127128162208270366253238248
Capital Work in Progress0215575220538
0005000000
1734303997159209144162216
0000000180252234
Cash & Bank1884142193738
739899127149238285159152169
Total Assets219268267343526721899743814913

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
272338307910-11922258
Cash from Investing-8-12-13-28-109-75-93-11-15-48
Cash from Financing-132-1337562131-97-624
07-0-410-1216-16035

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
67.7359.1959.1959.1959.1959.1959.1958.2958.59
0.001.071.011.051.091.121.181.982.19
0.001.972.362.523.162.992.962.911.92
Government0.000.000.000.000.000.000.000.000.00
32.2637.7837.4537.2436.5636.7036.6736.8237.30

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03
Record Date

2026-09-03 - Bajaj Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Sep-2026.

2026-08-30
Copy of Newspaper Publication

2026-08-30 - Bajaj Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29
General Updates

2026-08-29 - Bajaj Healthcare Limited has informed the Exchange regarding the Inland Letters sent to Shareholders

2026-08-29
General Updates

2026-08-29 - Bajaj Healthcare Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year 2025-26

2026-08-29
Shareholders meeting

2026-08-29 - Bajaj Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026

2026-08-26
Copy of Newspaper Publication

2026-08-26 - Bajaj Healthcare Limited has informed the Exchange about Copy of Newspaper Publication with respect to 33rd Annual General Meeting of the Company

2026-08-21
ESOP/ESOS/ESPS

2026-08-21 - Bajaj Healthcare Limited has informed the Exchange regarding Allotment of 2500 Equity Shares.

2026-08-21
Options to purchase securities

2026-08-21 - Bajaj Healthcare Limited has informed the Exchange about Options to purchase securities (Allotment of equity shares pursuant to exercise of ESOPs)

2026-08-12
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

2026-08-12 - Bajaj Healthcare Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

News

Recent coverage and analyst commentary for BAJAJHCARE

Loading news…

🤖

AI Stock Analyst

Bajaj Healthcare Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login